This inventor holds 6 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2017-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Milpitas, CA (US) (2017 - 2022)
- Los Altos, CA (US) (2024)
Company Filing History:
Years Active: 2017-2024
Title: The Innovative Contributions of Xiang Shao
Introduction
Xiang Shao is a prominent inventor based in Milpitas, California, known for his significant contributions to the field of cancer treatment. With a total of six patents to his name, he has made remarkable strides in developing therapeutic methods that target specific cancer cells.
Latest Patents
Xiang Shao's latest patents focus on innovative methods for treating HLA-E-expressing cancers. One of his notable inventions involves the use of monoclonal antibodies that bind to the human natural killer cell inhibitory receptor group 2A (NKG2A). These antibodies exhibit high affinity and possess therapeutically desirable functional properties, making them valuable in cancer treatment. His patents also include immunoconjugates, bispecific molecules, and pharmaceutical compositions that incorporate these anti-NKG2A antibodies. Furthermore, he has developed nucleic acid molecules encoding these antibodies, expression vectors, and host cells, along with methods for treating cancer using these innovative therapies. Combination therapy is another aspect of his work, where anti-NKG2A antibodies are co-administered with additional agents, such as other antibodies, to enhance treatment efficacy.
Career Highlights
Xiang Shao is currently associated with Bristol-Myers Squibb Company, a leading biopharmaceutical firm. His work at the company has been instrumental in advancing cancer therapies and improving patient outcomes. His dedication to research and innovation has positioned him as a key figure in the field of oncology.
Collaborations
Xiang Shao has collaborated with notable colleagues, including Alan J. Korman and Zhehong Cai, who contribute to the research and development of groundbreaking cancer treatments.
Conclusion
Xiang Shao's innovative work in developing targeted cancer therapies through his patents showcases his commitment to advancing medical science. His contributions are paving the way for more effective treatments and improving the lives of cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile